Stromal cells and epigenetics: emerging key players of chronic inflammatory skin diseases

키워드

참고문헌 (78)

1. Manetti M, "Molecular morphology and function of stromal cells", Int J Mol Sci, 22, pp.13422~ (2021)
2. Novoseletskaya E, "Mesenchymal stromal cell-produced components of extracellular matrix potentiate multipotent stem cell response to differentiation stimuli", Front Cell Dev Biol, 8, pp.555378~ (2020)
3. Mueller SN, "Stromal cell contributions to the homeostasis and functionality of the immune system", Nat Rev Immunol, 9, pp.618~629 (2009)
4. Nunomura S, "Establishment of a mouse model of atopic dermatitis by deleting Ikk2 in dermal fibroblasts", J Invest Dermatol, 139, pp.1274~1283 (2019)
5. Löwa A, "Fibroblasts from atopic dermatitis patients trigger inflammatory processes and hyperproliferation in human skin equivalents", J Eur Acad Dermatol, 34, pp.e262~e265 (2020)
6. He Y, "Mediators of capillary-to-venule convertsion in the chronic inflammatory skin disease psoriasis", J Invest Dermatol, 142, pp.3313~3326 (2022)
7. Rodrigues M, "Wound healing : a cellular perspective", Physiol Rev, 99, pp.665~706 (2019)
8. Lee H, "Highlighted STAT3 as a potential drug target for cancer therapy", BMB Rep, 52, pp.415~423 (2019)
9. Andreol F, "Modulation of epigenetic targets for anticancer therapy : clinicopathological relevance, structural data and drug discovery perspectives", Curr Pharm Design, 19, pp.578~613 (2013)
10. Fardi M, "Epigenetic mechanisms as a new approach in cancer treatment : an updated review", Genes Dis, 5, pp.304~311 (2018)
11. Akar RO, "Key actors in cancer therapy : epigenetic modifiers", Turk J Biol, 43, pp.155~170 (2019)
12. Shuto T, "Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells", FASEB J : Off Publ Fed Am Soc Exp Biol, 20, pp.782~784 (2006)
13. Zhang S, "Targeting epigenetic regulators for inflammation : mechanisms and intervention therapy", MedComm, 3, pp.e173~ (2022)
14. Kim J, "The p300", CBP inhibitor A485 normalizes psoriatic fibroblast gene expression in vitro and reduces psoriasis-like skin inflammation in vivo, 2022, pp.143, 431~443
15. Reyes-Palomares A, "Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension", Nat Commun, 11, pp.1673~ (2020)
16. Ciesielski O, "The epigenetic profile of tumor endothelial cells. Effects of combined therapy with antiangiogenic and epigenetic drugs on cancer progression", Int J Mol Sci, 21, pp.2606~ (2020)
17. Shimizu H, "Shimizu's Dermatology", pp.1~42 (2016)
18. Buckley CD, "Stromal cells in chronic inflammation and tertiary lymphoid organ formation", Annu Rev Immunol, 33, pp.715~745 (2015)
19. Villa A, "A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo", Int J Cancer, 122, pp.2405~2413 (2008)
20. Kelsh-Lasher RM, "Integrin 41 and TLR4 cooperate to induce fibrotic gene expression in response to fibronectin’s EDA domain", J Invest Dermatol, 137, pp.2505~2512 (2017)
21. Kinchen J, "Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease", Cell, 175, pp.372~386 (2018)
22. Bhattacharjee O, "Unraveling the ECM-immune cell crosstalk in skin diseases", Front Cell Dev Biol, 7, pp.68~ (2019)
23. Smith RS, "Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation", Am J Pathol, 151, pp.317~322 (1997)
24. Georganas C, "Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts : the dominant role for NF-B but not C", EBP or c-Jun, 2000, pp.165, 7199~7206
25. Distler JH, "The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles", Proc Natl Acad Sci U S A, 102, pp.2892~2897 (2005)
26. Abonnenc M, "Extracellular matrix secretion by cardiac fibroblasts", Circ Res, 113, pp.1138~1147 (2013)
27. Gubán B, "Abnormal regulation of fibronectin production by fibroblasts in psoriasis", Brit J Dermatol, 174, pp.533~541 (2016)
28. Arasa J, "Defective induction of COX-2 expression by psoriatic fibroblasts promotes pro-inflammatory activation of macrophages", Front Immunol, 10, pp.536~ (2019)
29. Jiao D, "NOD2 and TLR2ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitislike skin inflammation", Cell Mol Immunol, 13, pp.535~550 (2016)
30. He H, "Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis", J Allergy Clin Immun, 145, pp.1615~1628 (2020)
31. Linthout SV, "Crosstalk between fibroblasts and inflammatory cells", Cardiovasc Res, 102, pp.258~269 (2014)
32. Coentro JQ, "Current and upcoming therapies to modulate skin scarring and fibrosis", Adv Drug Deliver Rev, 146, pp.37~59 (2019)
33. Cappellari GG, "Lack of fibronectin extra domain A alternative splicing exacerbates endothelial dysfunction in diabetes", Sci Rep-uk, 6, pp.37965~ (2016)
34. Sprague AH, "Inflammatory cytokines in vascular dysfunction and vascular disease", Biochem Pharmacol, 78, pp.539~552 (2009)
35. von Stebut E, "IL-17A in psoriasis and beyond : cardiovascular and metabolic implications", Front Immunol, 10, pp.3096~ (2020)
36. Anyfanti P, "Endothelial dysfunction in psoriasis : an updated review", Front Med, 9, pp.864185~ (2022)
37. Steinhoff M, "Role of vasculature in atopic dermatitis", J Allergy Clin Immunol, 118, pp.190~197 (2006)
38. Ma F, "Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis", Nat Commun, 14, pp.3455~ (2023)
39. Hanna CW, "Epigenetic regulation in development : is the mouse a good model for the human?", Hum Reprod Update, 24, pp.556~576 (2018)
40. Pinborg A, "Epigenetics and assisted reproductive technologies", Acta Obstet Gyn Scan, 95, pp.10~15 (2016)
41. Jabbari K, "Cytosine methylation and CpG, TpG(CpA)and TpA frequencies", Gene, 333, pp.143~149 (2004)
42. Liu H, "DNA methylation dynamics : identification and functional annotation", Brief Funct Genomics, 15, pp.470~484 (2016)
43. Zhang P, "Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris", J Dermatol Sci, 60, pp.40~42 (2010)
44. Zhou F, "Epigenome-wide association analysis identified nine skin dna methylation loci for psoriasis", J Investig Dermatol, 136, pp.779~787 (2016)
45. Gu X, "Correlation between reversal of DNA methylation and clinical symptoms in psoriatic epidermis following narrow-band UVB phototherapy", J Invest Dermatol, 135, pp.2077~2083 (2015)
46. Ovejero-Benito MC, "Histone modifications associated with biological drug response in moderate-to-severe psoriasis", Exp Dermatol, 27, pp.1361~1371 (2018)
47. Ma S, "Profiling chromatin regulatory landscape : insights into the development of ChIP-seq and ATAC-seq", Mol Biomed, 1, pp.9~ (2020)
48. Li J, "Progressive alopecia reveals decreasing stem cell activation probability during aging of mice with epidermal deletion of DNA methyltransferase 1", J Investig Dermatol, 132, pp.2681~2690 (2012)
49. Sen GL, "DNMT1 maintains progenitor function in self-renewing somatic tissue", Nature, 463, pp.563~567 (2010)
50. Ezhkova E, "Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells", Cell, 136, pp.1122~1135 (2009)
51. Sada A, "Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin", Nat Cell Biol, 18, pp.619~631 (2016)
52. Paquet-Fifield S, "A role for pericytes as microenvironmental regulators of human skin tissue regeneration", J Clin Investig, 119, pp.2795~2806 (2009)
53. Akar RO, "Key actors in cancer therapy : epigenetic modifiers", Turk J Biol, 43, pp.155~170 (2019)
54. Kim TH, "The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2, 4-dinitrofluorobenzene-induced dermatitis in NC", Nga mice, 2010, pp.10, 1310~1315
55. Kim HJ, "Age-related epigenetic regulation in the brain and its role in neuronal diseases", BMB Rep, 49, pp.671~680 (2016)
56. Lee JH, "Epigenetic modification is linked to Alzheimer’s disease : is it a maker or a marker?", BMB Rep, 43, pp.649~655 (2010)
57. Han J, "The characteristics of genome-wide DNA methylation in naïve CD4+ T cells of patients with psoriasis or atopic dermatitis", Biochem Biophys Res Commun, 422, pp.157~163 (2012)
58. Chen M, "The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance", Br J Dermatol, 158, pp.987~99344 (2008)
59. Kim TH, "The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2, 4-dinitrofluorobenzene-induced dermatitis in NC", Nga mice, 2010, pp.10, 1310~1315
60. Ming M, "Loss of sirtuin 1(SIRT1)disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge", J Allergy Clin Immunol, 135, pp.936~945 (2015)
61. Tovar-Castillo LE, "Under-expression of VHL and over-expression of HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with psoriasis", Int J Dermatol, 46, pp.239~246 (2007)
62. Kwon Y, "HDAC6 and CXCL13 mediate atopic dermatitis by regulating cellular interactions and expression levels of miR-9 and SIRT1", Front Pharmacol, 12, pp.691279~ (2021)
63. Reynolds G, "Developmental cell programs are co-opted in inflammatory skin disease", Science, 371, pp.6500~ (2021)
64. Rodda LB, "Single-cell RNA sequencing of lymph node stromal cells reveals nicheassociated heterogeneity", Immunity, 48, pp.1014~1028 (2018)
65. Guerrero-Juarez CF, "Singlecell analysis reveals fibroblast heterogeneity and myeloidderived adipocyte progenitors in murine skin wounds", Nat Commun, 10, pp.650~ (2019)
66. Efremova M, "CellPhoneDB : inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes", Nat Protoc, 15, pp.1484~1506 (2020)
67. Tung KY, "Epigenetics and Dermatology", pp.227~224 (2015), Academic Press
68. Yi JZ, "Epigenetic-modifying therapies : an emerging avenue for the treatment of inflammatory skin diseases", Exp Dermatol, 30, pp.1167~1176 (2021)
69. Zhang L, "Noval advance of histone modification in inflammatory skin diseases and related treatment methods", Front Immunol, 14, pp.1286776~ (2024)
70. Chen C, "CD147 Facilitates the pathogenesis of psoriasis through glycolysis and H3K9me3modification in keratinocytes", Research, 6, pp.0167~ (2023)
71. Huang S, "KMT2C induced by FABP5P3 aggravates keratinocyte hyperproliferation and psoriasiform skin inflammation by upregulating the transcription of PIK3R3", J Invest Dermatol, 143, pp.37~47 (2023)
72. Zhang T, "EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation", Cell Death Dis, 11, pp.826~ (2020)
73. Masalha M, "H3K27Ac modification and gene expression in psoriasis", J Dermatol Sci, 103, pp.93~100 (2021)
74. Xia X, "GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis", J Clin Invest, 130, pp.5180~5196 (2020)
75. Traisaeng S, "A derivative of butyric acid, the fermentation metabolite of staphylococcus epidermidis, inhibits the growth of a staphylococcus aureus strain isolated from atopic dermatitis patients", Toxins(Basel), 11, pp.311~ (2019)
76. Zhao M, "3D genome alterations in T cells associated with disease activity of systemic lupus erythematosus", Ann Rheum Dis, 82, pp.226~234 (2023)
77. Zhao M, "RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1", Arthritis Res Ther, 12, pp.R227~ (2010)
78. Tsou PS, "EZH2modulates the DNA methylome and controls T cell adhesion through junctional adhesion molecule A in lupus patients", Arthritis Rheumatol, 70, pp.98~108 (2018)

관련 논문AI추천